Unichem Laboratories sale its stake in Optimus Drugs
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Company appoints five new independent directors to reconstituted board
APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years
Completion of the demerger of Haleon and share consolidation of GSK
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Subscribe To Our Newsletter & Stay Updated